Overview

Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages...

Open

$0.00

Prior close

$39.19

Today's high

$0.00

Today's low

$0.00

52 Week high

$39.70

52 Week low

$37.00

News

GlobeNewsWire • 14 hours ago • TEVA

New Teva Study Identifies the Attributes that Healthcare Providers Prioritize when Selecting a Treatment for Tardive Dyskinesia in Older Patients

GlobeNewsWire • 15 hours ago • TEVA

Teva Highlights New Real-World Data Showing UZEDY® (risperidone) Outperforms Other Long-Acting Injectables in Keeping Schizophrenia Patients on Treatment, While Reducing Emergency Care and Healthcare Costs

GlobeNewsWire • 15 hours ago • TEVA

Teva Announces New Olanzapine LAI (TEV-'749) Post Hoc Data Highlighting High Rates of Stabilization and Long-Term Efficacy as Once-Monthly Subcutaneous Injectable for the Treatment of Schizophrenia in Adults

Schaeffers Research • 2 days ago • TEVA

Most Active Options Report: FPS, TEVA, AFL

Benzinga • 3 days ago • TEVA

Teva's Shares Now Trade Directly on the NYSE — Here's What Else Changed